Publications by authors named "Bimal V Patel"

Claim this Profile
R
Retrospective analysis of impact of automated insulin delivery technology on acute care utilisation from 2019 to 2021.
Janna Manjelievskaia, Viral N Shah, Anders L Carlson, Diana Isaacs, Sharon M Wang, Bimal V Patel

Diabet Med· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cost-Utility Analysis of Control-IQ Technology Relative to Conventional Insulin Therapy in Adults with Type 1 Diabetes.
Jolien De Meulemeester, Francesca Fiorentino, Nuno Picado, Margaretha M Visser, Bart Keymeulen, Bimal V Patel

Diabetes Technol Ther· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
HEDIS glycemic goal achieved using control-IQ Technology.
Bimal V Patel, Sharon M Wang, Laurel H Messer, Jordan E Pinsker, Miranda R Polin

Am J Manag Care· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Systematic review of disparities in continuous glucose monitoring and insulin pump utilization in the United States: Key themes and evidentiary gaps.
Pranav M Patel, Divya Thomas, Zhixi Liu, Sarah Aldrich-Renner, Marilee Clemons, Bimal V Patel

Diabetes Obes Metab· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of postmenopausal hormone therapy between 2002 and 2009.
Bruce Ettinger, Sharon M Wang, R Scott Leslie, Bimal V Patel, Michael J Boulware

Menopause· November 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is There a Relationship Between Part D Medication Adherence and Part C Intermediate Outcomes Star Ratings Measures?
Jamie T Ta, Sara C Erickson, Wenyi Amanda Qiu, Bimal V Patel

J Manag Care Spec Pharm· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of an integrated adherence program aimed to increase Medicare Part D star rating measures.
R Scott Leslie, Breanne Tirado, Bimal V Patel, Philip J Rein

J Manag Care Spec Pharm· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there an association between the high-risk medication star ratings and member experience CMS star ratings measures?
Sara C Erickson, R Scott Leslie, Bimal V Patel

J Manag Care Spec Pharm· November 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Benefit restrictions and gout treatment.
Sharon M Wang, Gustavus A Aranda, Sara Gao, Bimal V Patel

J Manag Care Pharm· June 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prescriber perceptions of a near real-time fax alert program for potential drug-drug interactions.
Edward P Armstrong, Sharon M Wang, Lisa E Hines, Bimal V Patel, R Scott Leslie

J Manag Care Spec Pharm· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of coverage gap reform on adherence to diabetes medications.
Feng Zeng, Bimal V Patel, Louis Brunetti

Am J Manag Care· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evaluation of a drug-drug interaction: fax alert intervention program.
Edward P Armstrong, Sharon M Wang, Lisa E Hines, Sara Gao, Bimal V Patel

BMC Med Inform Decis Mak· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Evolution of postmenopausal hormone therapy between 2002 and 2009.
Bruce Ettinger, Sharon M Wang, R Scott Leslie, Bimal V Patel, Michael J Boulware

Menopause· June 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure to intensify hypertension therapy after rejected aliskiren claims.
Feng Zeng, Jinhee Park, Craig A Plauschinat, Bimal V Patel

Clin Ther· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Part D coverage gap and adherence to diabetes medications.
Qian Gu, Feng Zeng, Bimal V Patel, Louis C Tripoli

Am J Manag Care· June 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of copayment on initiation of smoking cessation pharmacotherapy: an analysis of varenicline reversed claims.
Feng Zeng, Chieh-I Chen, Vera Mastey, Kelly H Zou, James Harnett, Bimal V Patel

Clin Ther· February 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The impact of value-based benefit design on adherence to diabetes medications: a propensity score-weighted difference in difference evaluation.
Feng Zeng, Jae Jin An, Robert Scully, Christina Barrington, Bimal V Patel

Value Health· January 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Utilization management for smoking cessation pharmacotherapy: varenicline rejected claims analysis.
Feng Zeng, Chieh-I Chen, Vera Mastey, Kelly H Zou, James Harnett, Bimal V Patel

Am J Manag Care· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Improved persistence and adherence to diuretic fixed-dose combination therapy compared to diuretic monotherapy.
Bimal V Patel, Rosemay A Remigio-Baker, Patrick Thiebaud, Ronald Preblick, Craig Plauschinat

BMC Fam Pract· November 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Adherence with single-pill amlodipine/atorvastatin vs a two-pill regimen.
Bimal V Patel, R Scott Leslie, Patrick Thiebaud, Michael B Nichol, Simon S K Tang

Vasc Health Risk Manag· October 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The demand for statin: the effect of copay on utilization and compliance.
Patrick Thiebaud, Bimal V Patel, Michael B Nichol

Health Econ· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of initial antihypertensive drug class on patient persistence and compliance in a usual-care setting in the United States.
Bimal V Patel, Rosemay A Remigio-Baker, Devi Mehta, Patrick Thiebaud, Feride Frech-Tamas

J Clin Hypertens (Greenwich)· September 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of rofecoxib withdrawal on cyclooxygenase-2 utilization among patients with and without cardiovascular risk.
Patrick Thiebaud, Bimal V Patel, Michael B Nichol

Value Health· January 2007

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of switching on compliance and persistence: the case of statin treatment.
Patrick Thiebaud, Bimal V Patel, Michael B Nichol, David M Berenbeim

Am J Manag Care· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy.
Patrick W Sullivan, Kavita V Nair, Bimal V Patel

Am J Manag Care· June 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis